Advisor OS’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
+675
New +$250K 0.02% 484
2026
Q1
Sell
-1,830
Closed -$642K 594
2025
Q4
$642K Buy
1,830
+58
+3% +$19.6K 0.05% 243
2025
Q3
$573K Buy
1,772
+102
+6% +$31.7K 0.05% 236
2025
Q2
$650K Buy
1,670
+1,075
+181% +$432K 0.06% 211
2025
Q1
$259K Buy
+595
New +$239K 0.03% 357
2024
Q3
Sell
-380
Closed -$206K 414
2024
Q2
$206K Buy
+380
New +$201K 0.02% 374
2024
Q1
Sell
-551
Closed -$260K 393
2023
Q4
$260K Buy
+551
New +$255K 0.03% 281

Other funds holding ELV

Advisor OS's ELV Position: Q2 2026 in Review

Advisor OS opened a new position in Elevance Health (ELV) in Q2 2026: 675 shares worth $261K. The stake represents 0.02% of the portfolio and ranks #484 among its holdings. This is a return to the name: Advisor OS previously reported a position in ELV as recently as Q4 2025.

Advisor OS first reported a position in ELV in Q4 2023 and has held it in 7 quarters since. The position peaked at $650K in Q2 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Advisor OS held 675 shares of Elevance Health worth $261K as of Q2 2026.
  • Elevance Health was a new Advisor OS position in Q2 2026.
  • Elevance Health made up 0.02% of Advisor OS's portfolio in Q2 2026, its #484 holding.
  • Advisor OS first reported a position in Elevance Health in Q4 2023 and has held it in 7 quarters since.
  • Advisor OS's Elevance Health position peaked at $650K in Q2 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Advisor OS's 13F filing for Q2 2026, filed 5 Aug 2026.